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Summary 
 
Introduction: Appendicovesicostomy (APV) and Monti ileovesicostomy (Monti) are 
commonly used catheterizable channels with similar outcomes on short-term follow-up.  
Their relative long-term results have not been previously published. 
 
Objective:  Our goal was to assess long-term durability of APV and Monti channels in a 
large patient cohort. 
 
Study design:  In this retrospective cohort study, we retrospectively reviewed 
consecutive patients ≤21 years old undergoing APV and Monti surgery at our institution 
(1990-2013).  We collected data on demographics, channel type, location, continence and 
stomal and subfascial revisions. Kaplan-Meier survival and Cox proportional hazards 
analysis were used. 
 
Results: Of 510 patients meeting inclusion criteria, 214 patients had an APV and 296 had 
a Monti (50.5% spiral Monti).  Median age at surgery was 7.4 years for APV (median 
follow-up: 5.7 years) and 8.7 years for Monti (follow-up: 7.7 years).  Stomal stenosis, 
overall stomal revisions and channel continence were similar for APV and Monti 
(p≥0.26).  Fourteen APVs (6.5%) had subfascial revisions compared to 49 Montis 
(16.6%, p=0.001).  On survival analysis, subfascial revision risk at 10 years for APV was 
8.6%, Monti channels excluding spiral umbilical Monti: 15.5% and spiral umbilical 
Monti: 32.3% (p<0.0001, Figure).  On multivariate regression, Monti was 2.09 times 
more likely than APV to undergo revision (p=0.03).  The spiral Monti to the umbilicus, 
in particular, was 4.23 times more likely than APV to undergo revision (p<0.001).  
Concomitant surgery, gender, age and surgery date were not significant predictors of 
subfascial revision (p≥0.17).  Stomal location was significant only for spiral Montis. 
 
Discussion:  We present the first long-term results comparing the APV and Monti 
channels in a large patient population.  Our study has several limitations.  It is a 
retrospective, single center series rather than a randomized controlled trial.  While 
controlling for surgery date was a limited way of adjusting for changing surgical 
techniques, residual confounding by surgical technique is unlikely, as channel 
implantation technique was typically unrelated to channel type.  Our intention was to 
focus on channel reoperation, which entails the highest morbidity and cost.  We did not 
include complications managed conservatively or endoscopically.  In addition, while we 
did not capture patients who were lost to follow-up and possibly developed 
complications, we attempted to control for this through survival analysis.  Importantly, it 
is unlikely that the relative risk of subfascial complications between channel groups 
would change, as being lost to follow-up is probably unrelated to channel type. 
 
Conclusions: We demonstrate, durable long-term results with the APV and Monti 
techniques.  The risk of channel complications continues over the channel’s lifetime, with 
no difference in stomal complications between channels.  At 10 years after initial surgery, 
Monti channels were twice as likely to undergo a subfascial revision (1 in 6) than APV (1 
in 12).  The risk is even higher in for the spiral umbilical Monti (1 in 3). 
 
 
Figure.  Kaplan–Meier estimates of remaining without a subfascial revision, stratified by 
appendicovesicostomy, spiral umbilical Monti and other Monti channels. 
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Introduction 
 
Since first being described in 1980, the appendix has played an integral role in the 
creation of continent catheterizable channels using the Mitrofanoff principle.[1]  When it 
is not usable or available for an appendicovesicostomy (APV), other tissue may be used, 
particularly the transversely tubularized continent ileovesicostomy described by Yang [2] 
and Monti [3] (Monti), and later modified by Casale [4] (spiral Monti).  We have recently 
reported long-term results from a large cohort of patients after a Monti procedure, noting 
an increased risk of subfascial revisions among spiral Monti channels to the umbilicus, 
likely due to a long, unsupported extravesical segment.[5]   
When comparing APV and Monti techniques, at least 10 small series reported 
similar short-term rates of subfascial revisions.[6-15]  Our initial series of urinary 
channels demonstrated more complications among APV than Monti channels, but the 
APV group had much longer follow-up.[16]  Despite several decades of use, no direct 
comparison of long-term results of APV and Monti channels exists.  The goal of this 
study was to assess the durability of the APV compared to the Monti channel, focusing 
on stomal and subfascial revisions. 
 
Methods 
 
Patient selection and data collection 
We performed a retrospective review of consecutive patients ≤21 years old 
undergoing APV or Monti surgery at our institution (1990-2013). Those with continent 
urinary reservoirs, double Montis and channels made of tissue other than appendix or 
ileum were excluded.  To ensure a comprehensive assessment of channel outcomes and 
not ignore early complications, no minimum follow-up was required.  We collected data 
on demographics and surgery, including channel type and stomal location.  
 
Study outcomes 
Primary outcomes were subfascial and stomal revisions.  Indications for 
reoperation were secondary outcomes.  Suprafascial revisions for stomal stenosis, 
prolapse or granulation tissue were categorized as stomal revisions.  Subfascial revisions 
included a laparotomy for channel angulation or diverticulum resulting in catheterization 
difficulties, and incontinence due to inadequate tunnel length.  Among patients with 
multiple subfascial revisions of the same channel, time to first revision was used for 
analysis. 
 
Risk factors 
Given our previous work indicating that spiral Monti channels with umbilical 
stomas have a higher risk of subfascial revisions, [5] we compared three groups:  APV, 
spiral umbilical Monti and all other Monti channels.  Risk factors selected for the 
multivariate analysis included stomal location, gender, age at and date of surgery.  Stomal 
location was categorized as umbilical or non-umbilical (right or left lower quadrants).  
Age at surgery was categorized into 3 clinically meaningful groups:  <8 years, 8 to <16 
and ≥16.  To adjust for changing practices and surgical techniques, date of surgery was 
dichotomized as occurring within the last 10 years or before, a relatively arbitrary cutoff.  
While exact surgical technique details were unavailable for each case, over the last 
decade, channels were typically made with a 4cm submucosal tunnel in the anterior 
bladder wall and a V-skin flap stoma.  Intravesical implantation was typically favored if 
the bladder was opened (i.e. concomitant bladder augmentation) and an extravesical 
channel was favored if it was the only procedure preformed.  Channel type was dictated 
by surgeon preference and appendix availability. 
 
Statistical analysis 
Categorical variables were analyzed by Fisher’s exact test, continuous ones by the 
Mann-Whitney U test.  Kaplan-Meier analysis and Cox proportional hazards modeling 
were used, with proportional hazards assumptions verified by log-log plots and the 
nonzero slope test of the scaled Schoenfeld residuals.  The final model did not include the 
diagnosis of spinal dysraphism, because it did not satisfy the proportional hazards 
assumption.  Spinal dysraphism was not associated with the risk of a subfascial revision 
and the overall results did not change when it was included.   
To assess changes in risk between first 5 years of follow-up and the second 5 
years (5-10 years), we calculated the difference in risk at 5- and 10-year time points from 
the survival analysis.  While other time points could be chosen, these are helpful in 
counseling and our previous work indicates risk may decrease after 5 years.[5]  Statistical 
analyses were performed with a critical p=0.05 using Stata (v.10.1). 
 
Results 
 
Population characteristics 
Of 510 patients meeting inclusion criteria, 214 patients had an APV (40.4% were 
split appendix, using proximal appendix for a concomitant antegrade continence enema 
procedure).  The remaining 296 patients had a Monti, of whom half (50.5%) had a spiral 
Monti.  The two groups had similar rates of concomitant bladder augmentation (53.7% 
vs. 54.7%, p=0.86) and Malone antegrade continence enema procedures (59.8% vs. 
55.4%, p=0.36) (Table 1).  The two groups differed in several regards.  Patients 
undergoing an APV were less likely to have a concomitant bladder neck procedure 
(33.6% vs. 44.9%, p=0.01), but were more likely to be male (62.1% vs. 46.0% male, 
p<0.001).  Median age at surgery for patients with an APV was 7.4 years (range 1.9-20.5 
years) compared to 8.7 years (range 0.8-20.9 years) for a Monti (p=0.003).   
Median follow-up for patients with an APV was about 2 years shorter than for a 
Monti (5.7 vs. 7.7 years, p=0.01).  This was likely because a larger portion of APVs were 
performed recently, with 65.9% constructed in the last decade compared to 54.1% Monti 
channels (p=0.01).  Patients with APV were more likely to have an umbilical stoma 
(44.9% vs. 35.8%, p=0.04) and an underlying diagnosis other than spinal dysraphism 
(62.6% vs. 25.3%, p<0.001). 
 
Stomal revisions 
Twenty-five APVs (11.7%) underwent a stomal revision at median 1.3 years after 
initial channel surgery (range: 2 months-9.8 years).  The most common indication was 
stomal stenosis (7.5% overall).  Other indications included stomal prolapse (4), 
granulation tissue (3), channel angulation (1) or polyp (1). 
Twenty-eight Montis (9.9%) underwent a stomal revision at median 1.6 years 
(range: 5 months-8.5 years), similar to the APV group (log-rank: p=0.26).  The most 
common indication was stomal stenosis (7.4% overall), similar to APV (p=0.99).  The 
remaining stomas were revised for stomal prolapse (3), granulation tissue (1), channel 
angulation (1) or diverticulum (1).   
 
Subfascial revisions 
Primary subfascial revision was performed in 14 patients (6.5%) with an APV at a 
median 2.3 years after initial channel surgery (range:  5 months-15.1 years).  Most 
commonly, channels were revised due to difficult catheterizations secondary to channel 
stenosis/stricture (3.7%) and channel angulation (1.4%).  Two patients (0.9%) underwent 
subfascial revision for channel incontinence and one (0.5%) to repair an enterovesical 
fistula causing difficult catheterizations. 
Secondary revisions were performed in two patients (14.3% of primary revisions) 
for new channel incontinence at 9 months and 2.1 years after primary revision.  Given 
two primary revisions and two secondary revisions for incontinence, continence over the 
lifetime of the channel was 98.1%. 
Primary subfascial revision was performed in 49 patients (16.6%) with a Monti at 
a median of 2.3 years after the initial surgery (range:  5 months-12.4 years), which was 
higher than APV (p=0.001).  Time to subfascial revision was similar between groups 
(p=0.21).  Most common indications included difficult catheterizations due to channel 
stenosis/stricture (4.1%), channel angulation (8.4%) and channel diverticulum (0.3%).  
Others underwent surgery for incontinence (3.4%) and channel perforation (0.7%). 
There were 6 secondary revisions (12.8% of primary revisions) for incontinence 
(3), channel angulation (2), and channel diverticulum (1) at a median 3.5 years after 
primary subfascial revision (range:  7 months-8.6 years).  Given 10 incontinent channels 
(9 primary revisions, 2 secondary revisions for recurrent incontinence, 1 secondary 
revision for new incontinence), continence over the lifetime of the channel was 96.6%.  
This was statistically indistinguishable from the APV (p=0.41).  No channel underwent a 
third revision. 
 
Risk of subfascial revision by channel type 
Stratifying channels by stomal location, the proportion of channels undergoing 
subfascial revision ranged from 5.1% to 32.1% (Table 2).  After correcting for 
differential follow-up time, the risk of subfascial revision was significantly different 
between channel groups (log-rank: p=0.0006, Figure 1a). The risk of subfascial revision 
was indistinguishable between the umbilical and non-umbilical APV (log-rank: p=0.44), 
and APV channels made from split appendix versus an entire appendix (log-rank: 
p=0.31). 
Compared to non-umbilical APV, spiral umbilical Monti channels had a higher 
revision risk (log-rank: p<0.001).  Spiral and traditional Monti channels with non-
umbilical stomas also had higher revision risk (log-rank: p≤0.04) than non-umbilical 
APV.  Although traditional umbilical Monti channels clustered with other Monti channels 
on Kaplan-Meier plots, they did not reach statistical significance compared to the non-
umbilical APV (log-rank: p=0.12).  Since this was the smallest group with the fewest 
subfascial revisions, the log-rank test was likely underpowered to detect a difference.  
These results confirmed our intention to analyze channels in three groups for subsequent 
analysis:  APV, spiral umbilical Monti and all other Monti channels. 
Comparing the three groups, the risk of subfascial revision was lowest in the 
APV, highest in spiral umbilical Monti and intermediate in all other Monti channels (log-
rank: p<0.001) (Figure 1b).  For the APV, 6.4% and 8.6% of channels underwent a 
subfascial revision at 5 and 10 years after surgery, respectively (Table 3).  For the 
umbilical spiral Montis, 27.9% and 32.3% underwent a subfascial revision at 5 and 10 
years, respectively.  For all other Monti channels, 12.9% and 15.5% underwent a 
subfascial revision at 5 and 10 years, respectively. 
 Timing of subfascial revisions 
In terms of timing of revisions, 78.6% of APV revisions occurred in the first 5 
years, compared to 83.3% for spiral umbilical Montis and 80.6% for all other Montis.  
Using survival analysis data for each group, we calculated the change in risk of revision 
in the first and second 5 years of follow-up.  The risk of subfascial revision continued to 
increase between years 5-10 for each of the groups (by +2.2% to +4.4%), but this 
increase was consistently smaller than the risk observed during years 0-5 (+6.4% to 
+27.9%). 
 
Risk factors of subfascial revision 
On univariate Cox proportional hazards regression, overall stomal location, 
concomitant surgeries, gender, age at surgery and surgery within the past 10 years were 
not associated with increased risk of subfascial revision (p≥0.10) (Table 3).  Compared to 
the APV, spiral umbilical Monti had a 4.58-fold increased risk of revision (p<0.001) and 
all other Monti channels had a 1.95-fold increased risk (p=0.04).  These associations 
persisted on multivariate analysis when controlling for overall stomal location, 
concomitant surgeries, gender, age and date of surgery (spiral umbilical Monti:  HR 4.23, 
p<0.001, all other Monti channels:  HR 2.09, p=0.03).  No other variables were 
associated with the risk of subfascial revision on multivariate regression (p≥0.17). 
 
Discussion 
 
Based on a large cohort of patients with catheterizable urinary channels 
constructed in childhood and adolescence, we report long-term channel durability and 
excellent channel continence of 96-98%, which is consistent with our previous series and 
those of others.[7, 11, 12, 14, 17-23]  We found a persistent, but decreasing, risk of 
requiring a subfascial revision over the lifetime of the channel.  The risk of subfascial 
revisions is doubled for Monti compared to APV, with a quadrupling of risk for the spiral 
umbilical Monti.  Finally, concomitant surgeries were not associated with increased 
subfascial revision risk.  
Our findings support that the appendix, rather than reconfigured small bowel, is a 
preferred urinary catheterizable channel, not only because it avoids a bowel anastomosis, 
but also because of increased durability.  The absence of longitudinal suture lines, a 
naturally-occurring lumen and a mesentery spread over a longer portion of the channel 
may make the APV less predisposed to ischemia and trauma.  Trauma from recurrent 
catheterizations may result in an unsupported, elongated extravesical portion of the 
channel or a channel diverticulum.  Narayanaswamy et al. reported channel diverticula 
exclusively in a quarter of mostly double Monti channels, with one third requiring a 
revision, and none in an APV.[19]  Indeed, the only two patients in our study who 
developed a channel diverticulum had Monti channels.  Channel angulation and 
diverticulum were indications for 53% of primary Monti revisions vs. 21% of APV 
revisions.   
Three previous studies suggested Monti channels have a higher risk of 
complications than APV.  Although one series reported that 25 Monti channels had more 
catheterization problems than 69 APVs (60% vs. 26%), the overall risk of surgical 
intervention overall was similar at 3 years.[19]  Weikert et al. noted a possible trend 
toward higher channel-related complications in 12 spiral umbilical Montis compared to 
55 APV at 1.5 years.[24]  A report comparing 37 APV to 7 non-APV (2 Monti) found 
that non-APV channels had more difficulties with catheterizations, most commonly due 
to excessive extravesical length.[17] 
We identified 10 series reporting rates of complications and reoperations in APV 
and Monti channels to be similar.[6-15] Our initial report of short-term outcomes of 100 
catheterizable channels noted higher complications in APV than Monti (21% vs. 10%), 
but the APV group had longer follow-up (2.5 vs. 0.8 years).[16]  Similar to our initial 
report, previous studies presented short-term results at median follow-up of 2-4 years in a 
small number of channels, particularly Monti channels, and did not correct for differential 
follow-up time.  They were likely underpowered to detect differences between relatively 
rare outcomes.  In addition, some authors analyzed urinary and bowel channels together, 
[6, 7] while others grouped all complications, regardless if managed non-operatively or 
by endoscopic, stomal and subfascial interventions.[10, 15, 16] 
Our finding that umbilical stomas are associated with an increased revision risk in 
the typically longer, spiral Monti, but not the APV or traditional Monti, suggests that it 
may be channel length, rather than stomal location, which predisposes to complications.  
These findings are consistent with our previous reports on Monti channels[5, 25] and four 
other studies on catheterizable channels.[10, 11, 17, 20]  This reinforces that the ideal 
channel is straight, short, supple and well supported.   
While we agree that most channel complications occur early,[8, 10, 20] they can 
occur throughout the channel lifetime.  The last revision in our study occurred at 15.1 
years.  Survival curves do not appear to diverge for several years after surgery, 
suggesting that, after initial healing complications, subsequent problems may be due to 
channel “wear and tear”[10] or changes in body habitus. 
Our study has several limitations.  While it represents practices of seven 
experienced pediatric urologists over 24 years, it remains a retrospective, single center 
series rather than a randomized controlled trial.  While controlling for surgery date was a 
limited way of adjusting for changing surgical techniques, residual confounding by 
surgical technique is unlikely, as channel implantation technique was typically unrelated 
to channel type.  As our results originate from a high-volume center, they may not be 
generalizable to other clinical settings.  We did not assess obesity as a potential risk 
factor for channel complications and this will be a the focus of future work.  Our findings 
also underestimate overall channel complication risk.  Our intention was to focus on 
channel reoperation, which entails the highest morbidity and cost.  We did not include 
complications managed conservatively or endoscopically.  Between a third to half of 
cases of stomal stenosis [11, 12, 14, 15, 19, 20] or difficult catheterizations [23] can be 
managed conservatively.  One group successfully managed 82% of channel 
complications with endoscopic or stomal procedures.[8]  In addition, we did not capture 
patients who were lost to follow-up and possibly developed complications.  While the 
absolute risk of subfascial complications may possibly change if those patients were 
included, we attempted to control for this through survival analysis.  Importantly, it is 
unlikely that the relative risk of subfascial complications between channel groups would 
change, as being lost to follow-up is probably unrelated to channel type. 
 
Conclusions 
 
We showed durable, long-term results with APV and Monti techniques.  The risk 
of channel complications continues over the channel’s lifetime, with a marked reduction 
after 5 years of follow-up.  There was no difference in stomal complications between 
channels.  At 10 years after initial surgery, Monti channels were twice as likely to 
undergo a subfascial revision (1 in 6) than APV (1 in 12).  The risk is even higher in for 
the spiral umbilical Monti (1 in 3). 
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Tables 
Variable Appendicovesicostomy 
(n=214) 
Monti  
(n=296) 
p-value 
Male gender 133 (62.1%) 136 (46.0%) <0.001 
Caucasian race 189 (88.3%) 273 (92.2%) 0.17 
    
Age at surgery (years)    
   <8 years old 122 (57.0%) 134 (45.3%) 0.03 
   8 to <16 years old 71 (33.2%) 128 (43.2%)  
   ≥16 years old 21 (9.8%) 34 (11.5%)  
Median age at surgery (years, range) 7.4 (1.9-20.5) 8.7 (0.8-20.9) 0.003 
    
Surgery within last 10 years (≥2003) 141 (65.9%) 160 (54.1%) 0.01 
Median follow-up (years, range) 5.7 (0.1-23.3) 7.7 (0.1-15.8) 0.01 
    
Stomal location    
Umbilical stoma 96 (44.9%) 106 (35.8%) 0.04 
Non-umbilical stoma 118 (55.1%) 190 (64.2%)  
    Right lower quadrant     113 (52.8%)     183 (61.8%)  
    Left lower quadrant     5 (2.3%)     7 (2.4%)  
    
Concomitant surgeries    
Bladder augmentation 115 (53.7%) 162 (54.7%) 0.86 
Bladder neck procedure 72 (33.6%) 133 (44.9%) 0.01 
    Bladder neck sling 25 (11.7%) 84 (28.4%)  
    Bladder neck reconstruction 47 (22.0%) 73 (24.7%)  
    Bladder neck closure 4 (1.9%) 4 (1.4%)  
    Artificial urinary sphincter 0 (0.0%) 2 (0.7%)  
Malone antegrade continent enema 128 (59.8%) 164 (55.4%) 0.36 
    
Underlying diagnosis    
Myelodysplasia (lipo/myelomeningocele) 80 (37.4%) 221 (74.7%) <0.001 
Sacral agenesis 4 10  
Other spinal dysraphism 7 6  
Trauma 14 12  
Oncologic 2 3  
Exstrophy-epispadias 36 6  
Cloacal exstrophy 2 10  
Cloaca/urogenital sinus 10 6  
Posterior urethral valves 20 3  
Imperforate anus 6 9  
Non-neurogenic neurogenic bladder 12 0  
Cerebral palsy 6 4  
Other 15 6  
Table 1.  Patient characteristics. 
 
Channel type and 
stomal location Number 
Number of first 
subfascial revisions P-value 
Median follow-up 
(years) 
Appendicovesicostomy     
     Non-umbilical 118 6 (5.1%) reference 5.4 
     Umbilical 96 8 (8.3%) 0.41 6.2 
Monti     
Traditional     
   Non-umbilical 96 14 (14.6%) 0.03 8.4 
   Umbilical 50 6 (12.0%) 0.19 9.9 
Spiral     
   Non-umbilical 94 11 (11.7%) 0.13 4.8 
   Umbilical 56 18 (32.1%) <0.001 9.0 
Table 2.  Subfascial revisions stratified by channel type and stomal location (Fisher’s 
exact test). 
 
Channel type At 5 years At 10 years 
Appendicovesicostomy 6.4% 8.6% 
All other Monti channels 12.9% 15.5% 
Spiral umbilical Monti 27.9% 32.3% 
Table 3. Risk of subfascial revision. 
 
Variable 
Univariate Multivariate 
HR (95% CI) p-value HR (95% CI) p-value 
Channel type     
     Appendicovesicostomy 1.00 (reference) n/a 1.00 (reference) n/a 
     All other Monti channels 1.95 (1.03-3.69) 0.04 2.09 (1.07-4.07) 0.03 
     Spiral umbilical Monti channel 4.58 (1.26-9.27) <0.001 4.23 (1.91-9.37) <0.001 
Umbilical vs. non-umbilical stoma 1.39 (0.85-2.28) 0.19 1.14 (0.60-2.27) 0.72 
Concomitant surgeries     
    Bladder augmentation 1.30 (0.78-2.18) 0.32 1.32 (0.78-2.23) 0.30 
    Bladder neck procedure 1.52 (0.93-2.50) 0.10 1.36 (0.81-2.28) 0.25 
    Malone antegrade continence enema 0.80 (0.49-1.31) 0.38 0.78 (0.47-1.30) 0.34 
     
Male vs. female 1.09 (0.66-1.78) 0.74 1.14 (0.68-2.02) 0.62 
Age at surgery     
     <8 years old 1.18 (0.69-2.03) 0.55 1.17 (0.68-2.02) 0.58 
     8 to <16 years old 1.00 (reference) n/a 1.00 (reference) n/a 
     ≥16 years old 1.80 (0.83-3.91) 0.14 1.77 (0.79-3.86) 0.17 
Surgery within last 10 years vs. earlier 1.06 (0.62-1.79) 0.84 1.46 (0.82-2.58) 0.20 
Table 4. Risk factors for subfascial revision (HR:  hazard ratio).  
Figures 
 
 
 
Figure 1. Kaplan–Meier estimates of remaining without a subfascial revision, a) stratified 
by channel type and stomal location, and b) stratified by appendicovesicostomy, spiral 
umbilical Monti and other Monti channels.  
